LataMed AI Announces Forward Stock Split to Support Expansion in Latin America

LataMed AI Corp. (OTC: LMED), a digital health and artificial intelligence technology company focused on telehealth infrastructure for emerging markets, announced today that it expects to submit a corporate action request to FINRA for a five-for-one forward stock split. The proposed split, which includes proportional increases in authorized common and preferred stock, is intended to support the company’s long-term operational scalability and strategic growth initiatives as it expands its telehealth platform in Latin America.

The forward stock split would apply to all issued and outstanding shares of common stock and outstanding preferred stock designations, including the Series C Voting Preferred Stock. The company emphasized that the action does not involve debt restructuring, recapitalization, or reduction in shareholder ownership percentages. No fractional shares are expected to be issued; any fractional interests would be rounded up to the nearest whole share.

Dr. Kevin Rodan Levy, Chief Executive Officer of LataMed AI Corp., stated: “As we continue advancing our operational and commercialization initiatives throughout Latin America, we believe this proposed forward stock split and proportional capital structure expansion may support broader long-term strategic flexibility, operational scalability, and future growth initiatives as we continue building our healthcare technology platform.”

The announcement follows the company’s recent commencement of initial operational activities for its telehealth platform infrastructure in Venezuela, after receiving regulatory authorization from the Ministerio del Poder Popular para la Salud and Servicio Autonomo de Contraloria Sanitaria (SACS). This regulatory progression marks a key milestone for LataMed as it seeks to deploy digital healthcare solutions in emerging markets.

Management noted that the forward stock split is part of a broader effort to align the company’s capital structure with its transition into digital healthcare infrastructure and artificial intelligence-driven telehealth operations. The company believes this move will provide strategic flexibility for future growth initiatives, including further deployment of telehealth infrastructure, healthcare analytics integration, and commercialization efforts throughout Latin America and other targeted emerging markets.

The proposed corporate action remains subject to FINRA review and approval, completion of applicable regulatory processing, and final corporate implementation procedures. The company cautioned that no assurance can be provided regarding the timing or ultimate effectiveness of the proposed action.

LataMed AI Corp. is a development-stage enterprise that has not yet generated revenues from its current business operations. The company is focused on building a technology-enabled healthcare ecosystem designed to support remote patient engagement, provider coordination, healthcare analytics, and broader digital healthcare delivery initiatives. For more information, visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.

Forward-looking statements in this article are based on current expectations and assumptions, and actual results may differ materially due to risks including FINRA approval delays, regulatory challenges in emerging markets, and the company’s development-stage status.

This news story relied on content distributed by NewMediaWire. Blockchain Registration, Verification & Enhancement provided by NewsRamp. The source URL for this press release is LataMed AI Announces Forward Stock Split to Support Expansion in Latin America.

The post LataMed AI Announces Forward Stock Split to Support Expansion in Latin America appeared first on citybuzz.